ASTHENIA is the #6 most commonly reported adverse reaction for Ocrevus, manufactured by Genentech, Inc.. There are 2,685 FDA adverse event reports linking Ocrevus to ASTHENIA. This represents approximately 2.2% of all 124,640 adverse event reports for this drug.
Patients taking Ocrevus who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ASTHENIA2,685 of 124,640 reports
ASTHENIA is a less commonly reported adverse event for Ocrevus, but still significant enough to appear in the safety profile.
Other Side Effects of Ocrevus
In addition to asthenia, the following adverse reactions have been reported for Ocrevus:
ASTHENIA has been reported as an adverse event in 2,685 FDA reports for Ocrevus. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ASTHENIA with Ocrevus?
ASTHENIA accounts for approximately 2.2% of all adverse event reports for Ocrevus, making it a notable side effect.
What should I do if I experience ASTHENIA while taking Ocrevus?
If you experience asthenia while taking Ocrevus, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.